In Silico design of novel anticoagulant peptides targeting blood coagulation factor VIIa

Sultan Qaboos University Medical Journal

Volumn 11, Issue 1, 2011, Pages 83-94

  Al Amri, Manal S Q ^a   Alrasadi, Khalid ^b   Bayoumi, Riad ^a   Banerjee, Yajnavalka ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

Anticoagulant; Factor VIIa; In silico drug design

Indexed keywords

HEMACHATUS HAEMACHATUS;

EID: 79957965488     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Davie EW. Introduction to clotting in blood plasma. Methods Enzymol. 1981; 80:C153-6.
2. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30:10363-70.
3. Davie EW. Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 1995; 74:1-6.
4. Breitenstein A, Tanner FC, Luscher TF. Tissue factor and cardiovascular disease: quo vadis? Circ J 2010; 74:3-12.
5. Mackman N. The many faces of tissue factor. J Thromb Haemost 2009; 7:S136-9.
6. Butenas S, Orfeo T, Mann KG. Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol 2009; 29:1989-96.
7. Melnikova I. The anticoagulants market. Nat Rev Drug Discov 2009; 8:353-4.
8. Wittkowsky AK. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions. Semin Vasc Med 2003; 3:221-30.
9. Hirsh J. Heparin. N Engl J Med 1991; 324:1565-74.
10. Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991; 324:1865-75.
11. Trujillo TC. Emerging anticoagulants for venous thromboembolism prevention. Am J Health Syst Pharm 2010; 67:S17-25.
12. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 2002; 99:923-30.
13. Lorenzet R, Donati MB. Blood clotting activation, angiogenesis and tumor metastasis: any role for TFPI? Thromb Haemost 2002; 87:928-9.
14. Lee AY, Vlasuk GP. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor. J Intern Med 2003; 254:313-21.
15. Vlasuk GP, Rote WE. Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: from unique mechanism to a promising new clinical anticoagulant. Trends Cardiovasc Med 2002; 12:325-31.
16. Fluture A, Giugliano GR, Giugliano RP. Recombinant nematode anticoagulant protein c2 in non-ST segment elevation acute coronary syndrome and beyond. Future Cardiol 2007; 3:365-75.
17. Giugliano RP, Wiviott SD, Stone PH, Simon DI, Schweiger MJ, Bouchard A, et al. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial. J Am Coll Cardiol 2007; 49:2398-407.
18. Dennis MS, Eigenbrot C, Skelton NJ Ultsch MH, Santell L, Dwyer MA, et al. Peptide exosite inhibitors of factor VIIa as anticoagulants. Nature 2000; 404:465-70.
19. Dennis MS, Roberge M, Quan C, Lazarus RA. Selection and characterization of a new class of peptide exosite inhibitors of coagulation factor VIIa. Biochemistry 2001; 40:9513-21.
20. Maun HR, Eigenbrot C, Lazarus RA. Engineering exosite peptides for complete inhibition of factor VIIa using a protease switch with substrate phage. J Biol Chem 2003; 278:21823-30.
21. Roberge M, Santell L, Dennis MS, Eigenbrot C, Dwyer MA, Lazarus RA, et al. A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors. Biochemistry 2001; 40:9522-31.
22. Roberge M, Peek M, Kirchhofer D, Dennis MS, Lazarus RA. Fusion of two distinct peptide exosite inhibitors of Factor VIIa. Biochem J 2002; 363:387-93.
23. Uchiba M, Okajima K, Abe H, Okabe H, Takatsuki K. Effect of nafamostat mesilate, a synthetic protease inhibitor, on tissue factor-factor VIIa complex activity. Thromb Res 1994; 74:155-61.
24. Lazarus RA, Olivero AG, Eigenbrot C, Kirchhofer D. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy. Curr Med Chem 2004; 11:2275-90.
25. Buckman BO, Chou YL, McCarrick M, Liang A, Lentz D, Mohan R, et al. Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors. Bioorg Med Chem Lett 2005; 15:2249-52.
26. Banerjee Y, Lakshminarayanan R, Vivekanandan S, Anand GS, Valiyaveettil S, Kini RM. Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus. Biophys J 2007; 93:3963-76.
27. Banerjee Y, Kumar S, Jobichen C, Kini RM. Crystallization and preliminary X-ray diffraction analysis of hemextin A: a unique anticoagulant protein from Hemachatus haemachatus venom. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007; 63:701-3.
28. Banerjee Y, Mizuguchi J, Iwanaga S, Kini RM. Hemextin AB complex--a snake venom anticoagulant protein complex that inhibits factor VIIa activity. Pathophysiol Haemost Thromb 2005; 34:184-7.
29. Banerjee Y, Mizuguchi J, Iwanaga S, Kini RM. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity. J Biol Chem 2005; 280:42601-11.
30. Baxevanis AD. Searching the NCBI databases using Entrez. Curr Protoc Bioinformatics 2006; Ch.1:Unit 3.1.
31. Ji L, Barrett T, Ayanbule O, Troup DB, Rudnev D, Muertter RN, et al. NCBI Peptidome: a new repository for mass spectrometry proteomics data. Nucleic Acids Res 2010; 38:D731-5.
32. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10.
33. Madden TL, Tatusov RL, Zhang J. Applications of network BLAST server. Methods Enzymol 1996; 266:131-41.
34. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSIBLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389-402.
35. Notredame C, Higgins DG, Heringa J. T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol 2000; 302:205-17.
36. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003; 31:3784-8.
37. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISSMODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22:195-201.
38. Armano G, Manconi A. ProDaMa: an open source Python library to generate protein structure datasets. BMC Res Notes 2009; 2:202.
39. Fufezan C, Specht M. p3d--Python module for structural bioinformatics. BMC Bioinformatics 2009; 10:258.
40. Kini RM, Evans HJ. A novel approach to the design of potent bioactive peptides by incorporation of proline brackets: antiplatelet effects of Arg-Gly-Asp peptides. FEBS Lett 1995; 375:15-17.
41. Kini RM, Evans HJ. Prediction of potential proteinprotein interaction sites from amino acid sequence. Identification of a fibrin polymerization site. FEBS Lett 1996; 385:81-6.
42. Banner DW, D'Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380:41-6.
43. Menez A. Functional architectures of animal toxins: a clue to drug design? Toxicon 1998; 36:1557-72.
44. Weitz JI, Buller HR. Direct thrombin inhibitors in acute coronary syndromes: present and future. Circulation 2002; 105:1004-11.
45. Liu LW, Vu TK, Esmon CT, Coughlin SR. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem 1991; 266:16977-80.
46. Mathews II, Padmanabhan KP, Ganesh V, Tulinsky A, Ishii M, Chen J, et al. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry 1994; 33:3266-79.